BR1018-1
- Generic Name
- BR1018-1
A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- HypertensionHyperlipidemia (E.G., Hypercholesterolemia)
- Interventions
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2023-05-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 36
- Registration Number
- NCT05460364
- Locations
- 🇰🇷
Inha University Hospital, Incheon, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath